Szabo-Scandic and Next Generation Immunologists promote immunology research
Two young talents are currently being sponsored by Szabo-Scandic as part of the Immunis Sponsorship for Young Science (Immunis). Now the new turn starts. Szabo-Scandic and NGI – the junior organization of the Austrian Society for Allergology and Immunology young scientists ÖGAI – announce the Immunis 2022. The research sponsorship of total 7,500 euros is paid out in cash and research products. Registration is possible from now until June 30, 2022.
PhD students wanted
All doctoral candidates from the life science studies, i.e. human medicine, veterinary medicine, biology, bioinformatics, biotechnology, biochemistry and related subjects with a research topic in the field of immunology, allergology or vaccinology are eligible to apply. The dissertation must be supervised at an Austrian university, but may not be completed. This is because the Immunis is intended to support young researchers.
Sponsorship with a total value of 7,500 euros
The two best projects are nominated by an independent expert jury of the NGI. The award winner will receive a research sponsorship worth a total of 6,500 euros. Of this, EUR 5,000 will be paid out in materials, such as cell culture and consumable materials, research products, antibodies and diagnostic kits, and 1,500 euros in cash. The recognition prize will receive a cash prize of 1,000 euros.
All dissertations in the field of immunology, vaccinology and allergology may be submitted that started within the last two years (qualifying date June 30, 2020). To register, please use the form below.
Download Tender Documents
“The first Immunis last year showed that there is a great need to promote young talents. That's why we're now going into the next round with the immunis. We would like to make a contribution to encourage and support young scientists with their dissertations.”
“For us as NGI, the promotion of young researchers is a central concern. With the Immunis, we address young scientists at the beginning of their careers and can specifically promote them thanks to the support of Szabo-Scandic.”
The Immunis winners 2021
Last year’s winner of the Immunis sponsorship is Sarah Spöck, who assumes in her research project, that the epigenetic TET enzymes, TET2 and TET3, can prevent the development of autoimmune diseases, in particular the autoimmune lymphoproliferative disease (ALPS). "My work should help to decipher the molecular basis of autoimmune lymph proliferation and identify the vulnerabilities of a TET loss of function. I would like to lay the foundation for a possible therapy," says Sarah Spöck, describing the goal of her research project. Szabo-Scandic supports the researcher herself with a cash prize and the necessary equipment and research materials.
The recognition award went to Mustapha Jaiteh for his work on the immune memory of structural cells. The 28-year-old Phd student did his master's degree at the London School of Hygiene and Tropical Medicine (LSHTM), UK and has been working on his doctoral thesis at the CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences) in Vienna since January 2021. He investigates the concept of "immune memory" in structural cells, such as fibroblasts, epithelial and endothelial cells and wants to challenge the dogma that only immune cells have memory functions. Jaiteh is convinced that the discovery of an immunological recall function in structural cells would reveal a hitherto unrecognized property of the immune system that could be used in a targeted manner for therapeutic intervention.